| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.2 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |